Month: March 2007

Business 2.0 calls implantable devices one of “The jordan pas cher Top-10 Products, Ideas and Trends” destined to shape the future. While pharma’s busy trying to cope […]

According to a study released yesterday by the air max 97 pas cher University of New Hampshire’s Center for Venture Research, angel investing is up […]

San Francisco I-bank ThinkEquity Partners is out with its latest air max 270 pas cher healthcare newsletter, and it’s rife with interesting tid bits. In […]

The air max 270 noir Star Tribune ran a piece over the weekend about drug-device combos. It focused on Coon Rapids, Minnesota (a Minneapolis suburb)-based Possis […]

Cepheid, a Sunnyvale, CA molecular diagnostics company,yeezy pas cher got the nod from FDA today to market a rapid test for meningitis that differentiates between […]

PLC Medical Systems has enrolled the cheap trainers uk first patients in its FDA-approved clinical trial designed to evaluate the safety of its RenalGuard System. […]

Not being as closely scrutinized as the air max 90 homme pas cher pharmaceutical industry has its advantages. But now the medical device industry wants […]

A story in today’s The New York Times examines the issue of product-safety monitoring at medical device companies. The scope of the piece is limited in […]

Spectranetics Corporation has stopped enrolling patients in the air max 270 homme CELLO study after enrolling 61 of the planned 85 patients. Based on a […]

TheStreet.com’s Dick Arms says, go short on Conceptus. He points out that the air max 97 pas cher stock has built a top recently, opposed to going directly […]